Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...

FDA PDUFA review goal date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)Assuming ...

Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

The Food and Drug Administration (FDA) has approved neffy ® (epinephrine nasal spray) 1mg for the emergency treatment of type 1 allergic reactions, including anaphylaxis, in pediatric patients aged 4 ...

Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...

Shares of the company were up 5.2% in extended trading. The spray, sold under the brand name neffy, will be dosed at 1 ...

The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...

Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...

A Mass General Brigham-led study in preclinical models suggests that a nasal spray being tested for use in preventing Alzheimer’s disease could also reduce neuroinflammation in traumatic brain ...

The FDA (Food and Drug Administration) recently approved a new product, called ReCell, designed to treat severe burns to the body all with a single spray. Confused? Let’s start from the beginning.

CINCINNATI (WKRC) - The Food and Drug Administration issued a recall for certain nasal spray that tested positive for a bacterial contaminate that could lead to "potentially life-threatening ...

(WHTM) — The U.S. Food & Drug Administration (FDA) has announced the voluntary recall of a sinus nasal wash bottle system following a confirmed test result of microbial contamination. According ...